DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

Novartis

NYSE: NVS

71.90 -1.22 (-1.67%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $71.90 -1.67%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $72.60
Previous Close $73.12
Daily Range $71.89 - $73.31
52-Week Range $53.88 - $75.73
Market Cap $176.7B
P/E Ratio 18.80
Dividend (Yield) $2.53 (2.8%)
Ex-Dividend Date
Dividend Pay Date
02/26/13
04/05/13
Volume 990,418
Average Daily Volume 1,430,310
Current FY EPS $5.11

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

This Blockbuster Biologic May Face a Steep Cliff

Neulasta generated sales north of $4 billion for Amgen in 2012, but generic competition is brewing on two continents.

Novo Nordisk Patent Found Invalid - Analyst Blog

Pharma Rx? $105B Saved If Patients Took Meds

Positive Data on Novartis' Jakavi - Analyst Blog

Positive Data on Novartis' Jakavi - Analyst Blog

Positive Data on Incyte's Jakafi - Analyst Blog

Good News for InterMune - Analyst Blog

Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate

3 Humongous Health-Care Stocks This Week

These stocks skyrocketed this week. But will gravity soon kick in?

Encouraging Data on Novartis' Gilenya - Analyst Blog

Encouraging Data on Novartis' Gilenya - Analyst Blog

1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)

Two fascinating approaches pharmaceutical companies use to discover new drugs.

See More NVS News...

NVS's Top Competitors

NVS $71.90 (-1.67%)
Current stock: NVS
JNJ $84.86 (-1.74%)
Current stock: JNJ
MRK $47.58 (-0.36%)
Current stock: MRK
GSK $51.48 (-1.89%)
Current stock: GSK